...
Summer 2018 | Live Blog | Product Theater | Are Your Topical Patients Systemic Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
June 29, 2018

The second product theater on day 2 of the SDPA Annual Summer Conference presented by Robert Casquejo, PA-C discussed Otezla as a treatment for adult patients with active psoriatic arthritis and patients with moderate to severe plaque psoriasis who are candidates for phototherapy and systemic therapy. Otezla is an oral medication that inhibits phosphodiesterase 4 …

...
Summer 2018 | Live Blog | Product Theater | Innovations in Dermatology

The first product theater on day 2 of the SDPA Annual Summer Conference was presented by Dr. Neal Bhatia and featured the use of Onexton and Retin-A Micro for the treatment of acne. Acne vulgaris is an inflammatory pilosebaceous disease that affects greater than 80% adolescents, up to 12% women, and can persist after the …

...
Summer 2018 | Live Blog | Nephrocutaneous Disease: Review and Update

Day 2 of the SDPA Annual Summer Conference started with an enlightening lecture on nephrocutaneous disease presented by Dr. Jennie Clarke. For reasons that are not completely understood, xerosis and pruritis are the two most common presentations of patients with end stage renal disease. Unfortunately, dialysis does not help improve these conditions. Treatment of these …

...
Summer 2018 | Live Blog | Product Theater | More Than Skin Deep with Cosentyx (secukinumab): Proven Effective for Psoriatic Arthritis
June 28, 2018

Andrea Nguyen, MS, PA-C presented the second product theater on the first day of the SDPA Annual Summer Conference. She discussed Cosentyx, the first and only fully human Il-17A antagonist approved for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. Cosentyx is also indicated for the treatment of ankylosing spondylitis. Ms. Nguyen …

...
Summer 2018 | Live Blog | Comorbidities in Rosacea and Acne: Fact or Fiction?

Gina Fragione, MPAS, PA-C presented a lecture on Comorbidities in Rosacea and Acne: Fact or Fiction at the SDPA Annual Summer Conference. She began by discussing the pathophysiology of rosacea as primarily an inflammatory disorder consisting of a dysregulation of innate an adaptive immune system, and that it shares a common general pathophysiology with reported …

...
Summer 2018 | Live Blog | Comorbidities in Psoriasis: Fact or Fiction?

Did you know that over 20 comorbidities have been linked to Atopic Dermatitis in 2018? Dr. Robert Sidbury from Seattle Children’s Hospital helped attendees of the SDPA Summer Conference sift through the published data related to atopic comorbidities. Dr. Sidbury relayed that it is an “incredibly dynamic” time in the field of atopy in both …